BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37934582)

  • 1. A systematic framework for identifying prognostic necroptosis-related lncRNAs and verification of lncRNA CRNDE/miR-23b-3p/IDH1 regulatory axis in glioma.
    Chen Y; Hu D; Wang F; Huang C; Xie H; Jin L
    Aging (Albany NY); 2023 Nov; 15(21):12296-12313. PubMed ID: 37934582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA SNHG17 promotes proliferation, migration and invasion of glioma cells by regulating the miR-23b-3p/ZHX1 axis.
    Ge BH; Li GC
    J Gene Med; 2020 Nov; 22(11):e3247. PubMed ID: 32602607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA NNT-AS1 promote glioma cell proliferation and metastases through miR-494-3p/PRMT1 axis.
    Zheng D; Chen D; Lin F; Wang X; Lu L; Luo S; Chen J; Xu X
    Cell Cycle; 2020 Jul; 19(13):1621-1631. PubMed ID: 32420808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRNDE Promotes Malignant Progression of Glioma by Attenuating miR-384/PIWIL4/STAT3 Axis.
    Zheng J; Liu X; Wang P; Xue Y; Ma J; Qu C; Liu Y
    Mol Ther; 2016 Aug; 24(7):1199-1215. PubMed ID: 27058823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of lncRNA CRNDE attenuates nonsmall-cell lung cancer progression by mediating the miR-455-3p/HDAC2 axis.
    Li N; Chen XJ; Zeng YH; Zeng LP; Hu K; Chen LJ
    Kaohsiung J Med Sci; 2022 Aug; 38(8):749-760. PubMed ID: 35611803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA CRNDE promotes hepatocellular carcinoma progression by upregulating SIX1 through modulating miR-337-3p.
    Tang D; Zhao L; Peng C; Ran K; Mu R; Ao Y
    J Cell Biochem; 2019 Sep; 120(9):16128-16142. PubMed ID: 31099050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA CRNDE functions as a diagnostic and prognostic biomarker in osteosarcoma, as well as promotes its progression via inhibition of miR-335-3p.
    Yu Y; Wang L; Li Z; Zheng Y; Shi Z; Wang G
    J Biochem Mol Toxicol; 2021 May; 35(5):e22734. PubMed ID: 33522065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA CRNDE acts as an oncogene in cervical cancer through sponging miR-183 to regulate CCNB1 expression.
    Bai X; Wang W; Zhao P; Wen J; Guo X; Shen T; Shen J; Yang X
    Carcinogenesis; 2020 Mar; 41(1):111-121. PubMed ID: 31605132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Long Noncoding RNA CRNDE Increases Chemosensitivity of Medulloblastoma Cells by Targeting miR-29c-3p.
    Sun XH; Fan WJ; An ZJ; Sun Y
    Oncol Res; 2020 Feb; 28(1):95-102. PubMed ID: 31753063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRNDE affects the malignant biological characteristics of human glioma stem cells by negatively regulating miR-186.
    Zheng J; Li XD; Wang P; Liu XB; Xue YX; Hu Y; Li Z; Li ZQ; Wang ZH; Liu YH
    Oncotarget; 2015 Sep; 6(28):25339-55. PubMed ID: 26231038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA KTN1-AS1 promotes progression in pancreatic cancer through regulating microRNA-23b-3p/high-mobility group box 2 axis.
    Zhang ZB; Liu N
    Aging (Albany NY); 2021 Aug; 13(16):20820-20835. PubMed ID: 34461605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ceRNA network of lncRNA MIR210HG/miR-377-3p/LMX1A in malignant proliferation of glioma cells.
    Yu Z; Che N; He Y; Zhang B
    Genes Genomics; 2022 Dec; 44(12):1445-1455. PubMed ID: 36197580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA HNF1A-AS1 regulates proliferation and apoptosis of glioma through activation of the JNK signaling pathway via miR-363-3p/MAP2K4.
    Bi Y; Mao Y; Su Z; Du J; Ye L; Xu F
    J Cell Physiol; 2021 Feb; 236(2):1068-1082. PubMed ID: 32779194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomal lncRNA ROR1-AS1 Derived from Tumor Cells Promotes Glioma Progression via Regulating miR-4686.
    Chai Y; Wu HT; Liang CD; You CY; Xie MX; Xiao SW
    Int J Nanomedicine; 2020; 15():8863-8872. PubMed ID: 33204092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of long noncoding RNA CRNDE suppresses drug resistance of liver cancer cells by increasing microRNA-33a expression and decreasing HMGA2 expression.
    Han S; Han B; Li Z; Sun D
    Cell Cycle; 2019 Oct; 18(19):2524-2537. PubMed ID: 31416393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
    Li C; Feng S; Chen L
    Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. lncRNA PDCD4-AS1 Promotes the Progression of Glioma by Regulating miR-30b-3p/METTL7B Signaling.
    Li Z; Song Y; Zhang J
    Oxid Med Cell Longev; 2023; 2023():3492480. PubMed ID: 37151605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA SNHG6 promotes glioma tumorigenesis by sponging miR-101-3p.
    Meng Q; Yang BY; Liu B; Yang JX; Sun Y
    Int J Biol Markers; 2018 May; 33(2):148-155. PubMed ID: 29799357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA DLGAP1-AS1 promotes the progression of glioma by regulating the miR-1297/EZH2 axis.
    Liu L; Li X; Shi Y; Chen H
    Aging (Albany NY); 2021 Apr; 13(8):12129-12142. PubMed ID: 33901010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA PSMA3-AS1 promotes glioma progression through modulating the miR-411-3p/HOXA10 pathway.
    Huang T; Chen Y; Zeng Y; Xu C; Huang J; Hu W; Chen X; Fu H
    BMC Cancer; 2021 Jul; 21(1):844. PubMed ID: 34294084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.